UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-18 | Future report Set alerts | |
| Q2 2022 | 2022-07-21 | 1.50 | 1.50 |
| Q1 2022 | 2022-04-20 | 1.93 | 1.93 |
| Q4 2021 | 2022-02-07 | 2.70 | 2.70 |
| Q3 2021 | 2021-10-20 | 1.99 | 1.99 |
| Q2 2021 | 2021-07-21 | 1.59 | 1.59 |
| Q1 2021 | 2021-04-20 | 1.30 | 1.30 |
| Q4 2020 | 2021-02-09 | 4.72 | 4.72 |
| Q3 2020 | 2020-10-20 | 0.64 | -1.87 |
| Q2 2020 | 2020-08-03 | 1.26 | 0.83 |
| 2016-07-11 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-06-28 | Reiterated Rating | Credit Suisse | Hold | |
| 2016-06-28 | Reiterated Rating | Credit Suisse Group AG | Hold | |
| 2016-06-13 | Upgrade | Ladenburg Thalmann | Not Rated to Underperform | |
| 2016-05-16 | Reiterated Rating | Sterne Agee CRT | Buy | |
| 2016-05-16 | Reiterated Rating | Robert W. Baird | Buy | |
| 2016-05-05 | Reiterated Rating | JPMorgan Chase & Co. | Hold | $36.00 |
| 2016-05-04 | Boost Price Target | Citigroup Inc. | Neutral | $27.00 to $36.00 |
| 2016-05-04 | Downgrade | Mizuho | Buy to Neutral | $33.00 |
| 2016-05-03 | Reiterated Rating | Bank of America | Buy | |
| 2016-05-03 | Reiterated Rating | Morgan Stanley | Hold | |
| 2016-05-03 | Reiterated Rating | Credit Suisse | Hold | $31.00 |
| 2016-05-03 | Reiterated Rating | Bank of America Corp. | Buy | |
| 2016-05-02 | Reiterated Rating | Leerink Swann | Hold | |
| 2016-04-13 | Upgrade | Susquehanna | Neutral to Positive | $38.00 |
| 2016-03-24 | Boost Price Target | Credit Suisse | Neutral | $30.00 to $31.00 |
| 2016-03-16 | Boost Price Target | Mizuho | Buy | $30.00 to $33.00 |
| 2016-03-07 | Reiterated Rating | RBC Capital | Sector Perform | $37.00 to $30.00 |
| 2016-03-07 | Reiterated Rating | Royal Bank Of Canada | Sector Perform | $37.00 to $30.00 |
| 2016-03-02 | Reiterated Rating | Leerink Swann | Market Perform | $36.00 to $30.00 |
| 2016-02-26 | Lower Price Target | Susquehanna | $30.00 to $23.00 | |
| 2016-02-26 | Lower Price Target | BMO Capital Markets | Outperform | $55.00 to $38.00 |
| 2016-02-24 | Lower Price Target | SunTrust | Neutral | $34.00 to $28.00 |
| 2016-02-24 | Reiterated Rating | Barclays | Buy | $42.00 to $34.00 |
| 2016-02-24 | Lower Price Target | SunTrust Banks Inc. | Neutral | $34.00 to $28.00 |
| 2016-02-24 | Reiterated Rating | Barclays PLC | Buy | $42.00 to $34.00 |
| 2016-02-23 | Lower Price Target | Credit Suisse | Neutral | $33.00 to $30.00 |
| 2016-01-19 | Upgrade | Mizuho | Neutral to Buy | $30.00 |
| 2016-01-13 | Reiterated Rating | Mizuho | Neutral | |
| 2016-01-04 | Downgrade | Wells Fargo | Outperform to Market Perform | |
| 2016-01-04 | Downgrade | Wells Fargo & Co. | Outperform to Market Perform | |
| 2015-12-17 | Reiterated Rating | Credit Suisse | Hold | |
| 2015-12-16 | Initiated Coverage | Credit Suisse | Neutral | $33.00 |
| 2015-12-03 | Reiterated Rating | Mizuho | Hold | |
| 2015-12-02 | Boost Price Target | Mizuho | Neutral | $30.00 to $34.00 |
| 2015-11-06 | Lower Price Target | Raymond James | Outperform | $45.00 to $40.00 |
| 2015-11-06 | Lower Price Target | Raymond James Financial Inc. | Outperform | $45.00 to $40.00 |
| 2015-11-04 | Lower Price Target | JPMorgan Chase & Co. | Neutral | $52.00 to $38.00 |
| 2015-10-22 | Downgrade | Mizuho | Buy to Neutral | $68.00 to $30.00 |
| 2015-10-19 | Lower Price Target | Susquehanna | Neutral | $52.00 to $38.00 |
| 2015-10-08 | Reiterated Rating | Barclays | Overweight | $62.00 to $47.00 |
| 2015-10-02 | Initiated Coverage | Citigroup Inc. | Neutral | $40.00 |
| 2015-09-16 | Initiated Coverage | JPMorgan Chase & Co. | Neutral | $52.00 |
| 2015-09-10 | Initiated Coverage | Barclays | Overweight | $62.00 |
| 2015-09-06 | Upgrade | BMO Capital Markets | Market Perform to Buy | |
| 2015-08-31 | Upgrade | BMO Capital Markets | Market Perform to Outperform | $62.00 |
| 2015-07-22 | Initiated Coverage | Goldman Sachs | Hold | |
| 2015-07-22 | Initiated Coverage | Goldman Sachs Group Inc. | Hold | |
| 2015-07-21 | Reiterated Rating | Goldman Sachs | Neutral | $68.00 |
| 2015-06-30 | Reiterated Rating | Leerink Swann | Hold | |
| 2015-06-26 | Boost Price Target | Leerink Swann | Market Perform | $56.00 to $60.00 |
| 2015-06-26 | Reiterated Rating | Mizuho | Buy | $68.20 |
| 2015-06-26 | Reiterated Rating | Jefferies Group | Buy | $63.00 to $70.00 |
| 2015-06-26 | Upgrade | Wells Fargo & Co. | Market Perform to Outperform | $74.00 to $64.00 |
| 2015-06-26 | Upgrade | Wells Fargo | Market Perform to Outperform | $74.00 to $64.00 |
| 2015-06-10 | Initiated Coverage | Wedbush | Outperform | $60.00 |
| 2015-06-09 | Reiterated Rating | Jefferies Group | Buy | |
| 2015-03-26 | Initiated Coverage | Mizuho | Buy | $49.00 to $58.00 |
| 2015-03-24 | Reiterated Rating | SunTrust | Hold | $52.00 to $58.00 |
| 2015-03-23 | Reiterated Rating | Deutsche Bank | Buy | $75.00 |
| 2015-03-23 | Reiterated Rating | Deutsche Bank AG | Buy | $75.00 |
| 2015-03-05 | Downgrade | BMO Capital Markets | Outperform to Market Perform | $50.00 |
| 2015-02-26 | Reiterated Rating | Citigroup Inc. | Buy | $66.00 to $54.00 |
| 2015-02-03 | Upgrade | BMO Capital Markets | Market Perform to Outperform | $50.00 |
| 2015-02-02 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $59.00 to $51.00 |
| 2015-01-08 | Lower Price Target | Barclays | Overweight | $65.00 to $61.00 |
| 2014-12-18 | Initiated Coverage | Sterne Agee CRT | Buy | |
| 2014-10-16 | Boost Price Target | Robert W. Baird | Outperform | $65.00 to $74.00 |
| 2014-09-12 | Initiated Coverage | Leerink Swann | Market Perform | |
| 2014-09-09 | Boost Price Target | Deutsche Bank | Buy | $63.00 to $75.00 |
| 2014-08-14 | Boost Price Target | RBC Capital | Sector Perform | $43.00 to $62.00 |
| 2014-08-06 | Reiterated Rating | Citigroup Inc. | Buy | $52.00 to $66.00 |
| 2014-08-06 | Reiterated Rating | Credit Suisse | Neutral | $51.00 to $63.00 |
| 2014-08-06 | Boost Price Target | Barclays | $52.00 to $66.00 | |
| 2014-08-06 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $57.00 to $59.00 |
| 2014-08-06 | Upgrade | Raymond James | Market Perform to Outperform | $65.00 |
| 2014-08-05 | Downgrade | Mizuho | Buy | $59.00 to $64.00 |
| 2014-08-05 | Boost Price Target | Jefferies Group | Buy | $48.00 to $63.00 |
| 2014-06-13 | Downgrade | S&P Equity Research | Hold | |
| 2014-06-11 | Boost Price Target | Mizuho | Buy | $52.00 to $59.00 |
| 2014-06-03 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $52.00 to $57.00 |
| 2014-05-12 | Reiterated Rating | BMO Capital Markets | Market Perform | $45.00 to $47.00 |
| 2014-05-07 | Boost Price Target | FBR & Co. | Market Perform | $45.00 to $47.00 |
| 2014-03-31 | Initiated Coverage | Monness Crespi & Hardt | Neutral | |
| 2014-03-05 | Lower Price Target | RBC Capital | $47.00 to $43.00 | |
| 2014-03-03 | Reiterated Rating | BMO Capital Markets | Market Perform | $47.00 to $45.00 |
| 2014-02-25 | Downgrade | Susquehanna | Neutral | |
| 2014-02-25 | Downgrade | CRT Capital | Buy to Fair Value | $51.00 to $41.50 |
| 2014-01-31 | Boost Price Target | Leerink Swann | $107.00 to $130.00 | |
| 2014-01-08 | Downgrade | Raymond James | Outperform to Market Perform | $50.00 |
| 2013-11-21 | Lower Price Target | Credit Suisse | Outperform | $48.00 |
| 2013-11-13 | Boost Price Target | Mizuho | Buy | $49.00 to $52.00 |
| 2013-11-12 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | $50.00 |
| 2013-11-08 | Initiated Coverage | FBR & Co. | Market Perform | $49.00 |
| 2013-11-06 | Downgrade | Wells Fargo & Co. | Outperform to Market Perform | |
| 2013-11-06 | Downgrade | Wells Fargo | Outperform to Market Perform | |
| 2013-11-05 | Lower Price Target | Deutsche Bank | Buy | $65.00 to $60.00 |
| 2013-10-15 | Initiated Coverage | Barclays | Overweight to Overweight | $55.00 |
| 2013-10-08 | Upgrade | Goldman Sachs | Neutral to Buy | $47.00 to $55.00 |
| 2013-10-07 | Boost Price Target | Deutsche Bank | Buy | $55.00 to $65.00 |
| 2013-06-06 | Upgrade | Deutsche Bank | Hold to Buy | $49 to $55 |
| 2013-05-06 | Reiterated | Mizuho | Buy | $41 to $51 |
| 2013-01-03 | Upgrade | Imperial Capital | In-line to Outperform | $20 to $40 |
| 2016-07-11 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-06-28 | Reiterated Rating | Credit Suisse | Hold | |
| 2016-06-28 | Reiterated Rating | Credit Suisse Group AG | Hold | |
| 2016-06-13 | Upgrade | Ladenburg Thalmann | Not Rated to Underperform | |
| 2016-05-16 | Reiterated Rating | Sterne Agee CRT | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In THC 296 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Vanguard Group, Inc | 10.85M |
| BlackRock Inc. | 9.63M |
| GLENVIEW CAPITAL MANAGEMENT LLC | 8.10M |
| Invesco Ltd. | 6.69M |
| FMR LLC | 6.46M |
| HARRIS ASSOCIATES L P | 5.54M |
| BLACKROCK ADVISORS LLC | 4.52M |
| BlackRock Fund Advisors | 3.49M |
| Camber Capital Management LLC | 3.00M |
| STATE STREET CORP | 2.93M |
| SAMLYN CAPITAL, LLC | 2.81M |
| BlackRock Institutional Trust Company, N.A. | 2.74M |
| CANYON CAPITAL ADVISORS LLC | 1.88M |
| BlackRock Group LTD | 1.83M |
| DIMENSIONAL FUND ADVISORS LP | 1.77M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| FETTER TREVOR CEO and President | 1.13% (1108162) | HIG / THC / |
| PITTS KEITH B Vice Chairman | 0.24% (232524) | PINC / THC / |
| Cancelmi Daniel J Chief Financial Officer | 0.22% (219049) | THC / |
| Reynolds Britt T Pres. of Hospital Operations | 0.10% (96169) | THC / |
| GARRISON KAREN M | 0.08% (80061) | KAMN / THC / |
| GAINES BRENDA J | 0.08% (75677) | GAS / THC / |
| Fraser Cathy Senior Vice President | 0.08% (74330) | THC / |
| KANGAS EDWARD A Chairman | 0.08% (73882) | HOV / INTU / THC / UTX / |
| Andrews Audrey T. SVP and General Counsel | 0.07% (68639) | THC / |
| UNRUH JAMES A | 0.06% (59071) | CSGS / PRU / THC / |
| GLENVIEW CAPITAL MANAGEMENT LLC | 0.05% (52394) | CYH / FLEX / HMA / THC / WOOF / |
| PETTINGILL RICHARD | 0.05% (48630) | ARAY / HGR / MAKO / THC / |
| Evans Jason Eric Pres. of Hospital Operations | 0.05% (44206) | THC / |
| Rittenmeyer Ronald A | 0.05% (44155) | AIG / IMS / Q / THC / |
| WILVER PETER M | 0.03% (28889) | AQUA / CIR / THC / TMO / |
| Bush John Ellis | 0.03% (27790) | RYN / SWSH / THC / |
| Romo Tammy | 0.03% (27407) | LUV / THC / |
| BYRNES JOHN P | 0.02% (23889) | THC / |
| KERREY J ROBERT | 0.02% (18939) | JNY / THC / |
| Lewis-Hall Freda C | 0.02% (15314) | PFE / THC / |
| BIERMAN JAMES L | 0.01% (12847) | OMI / THC / TMH / |
| MARK RICHARD J | 0.01% (12430) | AEE / THC / |
| FISHER RICHARD W | 0.01% (12430) | PEP / T / THC / |
UM